137 related articles for article (PubMed ID: 37614422)
1. A successfully cured case of cytomegalovirus multiple organ infection after hematopoietic stem cell transplantation: A case report.
Li Q; Liang Q; Meng R; Xie Q; Zhang Y; Wei C; Wei Y; He K; Li M
Exp Ther Med; 2023 Sep; 26(3):454. PubMed ID: 37614422
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of 34 patients with cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation].
Li S; Shen ZH; Wan LP; Bao AH; Yang J; Tong Y; Wang C
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):843-847. PubMed ID: 33190442
[No Abstract] [Full Text] [Related]
3. Cytomegalovirus pneumonia in a patient with T-lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: A case report.
Li Q; Wang K; Guo W; Lu M
Medicine (Baltimore); 2019 Jan; 98(4):e14221. PubMed ID: 30681598
[TBL] [Abstract][Full Text] [Related]
4. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.
Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint MT; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont AM
Transplantation; 1996 Aug; 62(3):376-80. PubMed ID: 8779686
[TBL] [Abstract][Full Text] [Related]
5. Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide.
Huntley D; Giménez E; Pascual MJ; Hernández-Boluda JC; Gago B; Vázquez L; Piñana JL; García M; Pérez A; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Transpl Infect Dis; 2020 Feb; 22(1):e13206. PubMed ID: 31677215
[TBL] [Abstract][Full Text] [Related]
6. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
[No Abstract] [Full Text] [Related]
7. A clinical study of lyophilized intravenous human immunoglobulin containing high-titer cytomegalovirus-neutralizing antibody for the treatment of cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.
Zhang P; Yang D; Tian J; Feng S; Jiang E; Han M
Ann Palliat Med; 2021 May; 10(5):5533-5540. PubMed ID: 34107701
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of the curative effects of cytomegalovirus preemptive therapy in various kinds of hematopoietic stem-cell transplantation].
Zhao XS; Xu LP; Liu DH; Chen YH; Chen H; Zhang XH; Han W; Wang Y; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):476-80. PubMed ID: 19954043
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
Wang LR; Dong LJ; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
[TBL] [Abstract][Full Text] [Related]
10. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
11. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
Ehlert K; Groll AH; Kuehn J; Vormoor J
Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
Guo Z; Chen HR; Liu XD; Bian JM; He XP; Lou JX; Chen P; Yang K; Liu D; Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):971-4. PubMed ID: 22931666
[TBL] [Abstract][Full Text] [Related]
14. Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.
Talaya A; Giménez E; Piñana JL; Albert E; Hernández-Boluda JC; Pérez A; Torres I; Solano C; Navarro D
J Med Virol; 2019 Jun; 91(6):1128-1135. PubMed ID: 30735250
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of low cytomegalovirus viral load thresholds for preemptive antiviral therapy in hematopoietic cell transplant recipients].
Li L; Wang Y; Yan CH; Huang XJ
Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):191-195. PubMed ID: 29518863
[No Abstract] [Full Text] [Related]
16. Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report.
Pando-Caciano A; Escudero-Ramirez KA; Torres-Rodríguez JC; Maita-Malpartida H
Front Med (Lausanne); 2024; 11():1335969. PubMed ID: 38371512
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review.
Jerry Teng CL; Wang PN; Chen YC; Ko BS
J Microbiol Immunol Infect; 2021 Jun; 54(3):341-348. PubMed ID: 33514495
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group.
Solano C; Vázquez L; Giménez E; de la Cámara R; Albert E; Rovira M; Espigado I; Calvo CM; López-Jiménez J; Suárez-Lledó M; Chinea A; Esquirol A; Pérez A; Bermúdez A; Saldaña R; Heras I; González-Huerta AJ; Torrado T; Bautista G; Batlle M; Jiménez S; Vallejo C; Barba P; Cuesta MÁ; Piñana JL; Navarro D
Am J Transplant; 2021 Jan; 21(1):258-271. PubMed ID: 32812351
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal administration of high-titer cytomegalovirus immunoglobulin for cytomegalovirus meningitis.
Fujiwara S; Muroi K; Tatara R; Ohmine K; Matsuyama T; Mori M; Nagai T; Ozawa K
Case Rep Hematol; 2014; 2014():272458. PubMed ID: 24900929
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation].
Ding H; Ren H; Guo N; Huang X; Xu L; Zhang Y; Lu D
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):596-9. PubMed ID: 14710251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
